An interventional study of Experimental arm and Procedure/Standard care in Endovascular Treatments, Endovascular Surgery and Peripheral Arterial, sponsored by University Hospital, Brest. Not yet recruiting at 11 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-07.
Sponsored by University Hospital, Brest · Not applicable, Interventional, and Treatment
Endovascular treatment tends to replace open surgery in the management of peripheral arterial disease. Access via the common femoral artery remains the primary approach for peripheral arterial interventions. Brachial artery access has emerged as a valid alternative when femoral access is not feasible. Brachial access can be achieved either percutaneously or through an open surgical approach at the elbow.
A limited number of studies have reported complication rates associated with open and percutaneous brachial access in the treatment of peripheral arterial disease. These studies have shown higher complication rates for percutaneous access (ranging from 6% to 9%) compared with open brachial access (ranging from 1% to 2%). However, no direct comparison between the two approaches has been reported to date.
This study is the first to provide a direct, prospective, randomized comparison between open brachial access and percutaneous brachial access
University Hospital, Brest is the lead sponsor of 594 studies on the registry; 135 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Procedure: Experimental arm
Procedure: Procedure/Standard care
Endovascular procedure for peripheral arterial lesions via brachial access
Endovascular procedure for peripheral arterial lesions via femoral access
Occurrence of at least one complication (yes/no) at the access site
Time frame: Day 30
Occurrence of at least one major systemic complication (yes/no)
Time frame: Day 30
Measure of Quality of Life with the EQ5D-5L questionnary
Time frame: Day 30
Procedure time
Time frame: Day 1
Length of hospital stay.
Time frame: up to 2 years
Plan to share: Yes — All collected data that underlie results in a publication
Supporting information: Study protocol
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Brest